Zobrazeno 1 - 10
of 243
pro vyhledávání: '"S. De Lombaert"'
Autor:
Jinhui Wang1, Shengchun Wang2, Zhihong Wei3, Pengjie Wang2, Yanwei Cao1, Yang Huang1, Lin He1, Aiwen Lei2 helin@licp.cas.cn
Publikováno v:
Science. 11/15/2024, Vol. 386 Issue 6723, p776-782. 7p. 5 Diagrams.
Non-Peptidic CRF1 Receptor Antagonists for the Treatment of Anxiety, Depression and Stress Disorders
Autor:
S De Lombaert, John H. Kehne
Publikováno v:
Current Drug Target -CNS & Neurological Disorders. 1:467-493
Anxiety and depression are psychiatric disorders that constitute a major health concern worldwide, and new pharmacological approaches with the potential for improved efficacy and decreased side effect profiles relative to currently marketed drugs are
Autor:
Paula Savage, Angelo J. Trapani, Arco Y. Jeng, Charles W. Bruseo, Mary Chou, S. De Lombaert, Michael E. Beil
Publikováno v:
Life Sciences. 67:1025-1033
Endothelin-1 (ET- 1) is a potent vasoconstrictor. Its biosynthesis is catalyzed by endothelin converting enzyme (ECE). In contrast, atrial natriuretic peptide (ANP) is a potent vasorelaxant and diuretic, and it is mainly degraded by neutral endopepti
Autor:
John Moliterni, Arco Y. Jeng, John Fitt, Lisa B. Stamford, Eli M. Wallace, L. Blanchard, Mary Chou, S. De Lombaert, Jenny Tan, Paula Savage, Daniel Hoyer, N. Marcopoulos, D. Simonsbergen, Angelo J. Trapani, Yoshitaka Satoh
Publikováno v:
Journal of Medicinal Chemistry. 43:488-504
Potent and selective non-peptidic inhibitors of human endothelin-converting enzyme-1 (ECE-1) have been designed as potential modulators of endothelin (ET-1) production in vivo. Because of its unique structural characteristics and long duration of act
Autor:
Mark D. Erion, L. Blanchard, Angelo J. Trapani, L. El‐Chehabi, Jenny Tan, Carol Berry, R. D. Ghai, S. De Lombaert, Yumi Sakane
Publikováno v:
ChemInform. 25
Publikováno v:
ChemInform. 26
Publikováno v:
ChemInform. 26
Autor:
S. De Lombaert, Arco Y. Jeng
Publikováno v:
ChemInform. 29
Autor:
Michael A. Moskal, S. De Lombaert, Yoshitaka Satoh, John Moliterni, Jenny Tan, Nicholas Marcopulos, Eli M. Wallace
Publikováno v:
ChemInform. 29
Publikováno v:
Journal of Cardiovascular Pharmacology. 31:S68-S70
Optimization of an aminophosphonic acid series of compounds for inhibition of endothelin-converting enzyme (ECE) has led to the discovery of CGS 31447. This compound reversibly inhibited the activity of recombinant human ECE-1 with an IC50 value of 2